These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

70 related articles for article (PubMed ID: 18465891)

  • 21. Statin therapy is associated with reduced neuropathologic changes of Alzheimer disease.
    Siegel GJ; Chauhan NB; Feinstein DL; Li G; Larson EB; Breitner JC; Montine TJ
    Neurology; 2008 Jul; 71(5):383; author reply 383. PubMed ID: 18663190
    [No Abstract]   [Full Text] [Related]  

  • 22. Contrasting in vivo effects of two peptide-based amyloid-beta protein aggregation inhibitors in a transgenic mouse model of amyloid deposition.
    Li Q; Gordon M; Etienne MA; Hammer RP; Morgan D
    Cell Transplant; 2008; 17(4):397-408. PubMed ID: 18522242
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Postischemic treatment of neonatal cerebral ischemia should target autophagy.
    Puyal J; Vaslin A; Mottier V; Clarke PG
    Ann Neurol; 2009 Sep; 66(3):378-89. PubMed ID: 19551849
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Begacestat (GSI-953): a novel, selective thiophene sulfonamide inhibitor of amyloid precursor protein gamma-secretase for the treatment of Alzheimer's disease.
    Martone RL; Zhou H; Atchison K; Comery T; Xu JZ; Huang X; Gong X; Jin M; Kreft A; Harrison B; Mayer SC; Aschmies S; Gonzales C; Zaleska MM; Riddell DR; Wagner E; Lu P; Sun SC; Sonnenberg-Reines J; Oganesian A; Adkins K; Leach MW; Clarke DW; Huryn D; Abou-Gharbia M; Magolda R; Bard J; Frick G; Raje S; Forlow SB; Balliet C; Burczynski ME; Reinhart PH; Wan HI; Pangalos MN; Jacobsen JS
    J Pharmacol Exp Ther; 2009 Nov; 331(2):598-608. PubMed ID: 19671883
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Reduction of Alzheimer's disease amyloid plaque load in transgenic mice by D3, A D-enantiomeric peptide identified by mirror image phage display.
    van Groen T; Wiesehan K; Funke SA; Kadish I; Nagel-Steger L; Willbold D
    ChemMedChem; 2008 Dec; 3(12):1848-52. PubMed ID: 19016284
    [No Abstract]   [Full Text] [Related]  

  • 26. P-glycoprotein efflux and other factors limit brain amyloid beta reduction by beta-site amyloid precursor protein-cleaving enzyme 1 inhibitors in mice.
    Meredith JE; Thompson LA; Toyn JH; Marcin L; Barten DM; Marcinkeviciene J; Kopcho L; Kim Y; Lin A; Guss V; Burton C; Iben L; Polson C; Cantone J; Ford M; Drexler D; Fiedler T; Lentz KA; Grace JE; Kolb J; Corsa J; Pierdomenico M; Jones K; Olson RE; Macor JE; Albright CF
    J Pharmacol Exp Ther; 2008 Aug; 326(2):502-13. PubMed ID: 18499745
    [TBL] [Abstract][Full Text] [Related]  

  • 27. TREM2 is upregulated in amyloid plaque-associated microglia in aged APP23 transgenic mice.
    Frank S; Burbach GJ; Bonin M; Walter M; Streit W; Bechmann I; Deller T
    Glia; 2008 Oct; 56(13):1438-47. PubMed ID: 18551625
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The mitochondrial permeability transition pore.
    Bernardi P; Forte M
    Novartis Found Symp; 2007; 287():157-64; discussion 164-9. PubMed ID: 18074637
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Taurine protects transformed rat retinal ganglion cells from hypoxia-induced apoptosis by preventing mitochondrial dysfunction.
    Chen K; Zhang Q; Wang J; Liu F; Mi M; Xu H; Chen F; Zeng K
    Brain Res; 2009 Jul; 1279():131-8. PubMed ID: 19427840
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Neuroprotection of rapamycin in lactacystin-induced neurodegeneration via autophagy enhancement.
    Pan T; Kondo S; Zhu W; Xie W; Jankovic J; Le W
    Neurobiol Dis; 2008 Oct; 32(1):16-25. PubMed ID: 18640276
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Catalpol protects mesencephalic neurons against MPTP induced neurotoxicity via attenuation of mitochondrial dysfunction and MAO-B activity.
    Bi J; Wang XB; Chen L; Hao S; An LJ; Jiang B; Guo L
    Toxicol In Vitro; 2008 Dec; 22(8):1883-9. PubMed ID: 18840519
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Synaptic transmission is impaired prior to plaque formation in amyloid precursor protein-overexpressing mice without altering behaviorally-correlated sharp wave-ripple complexes.
    Hermann D; Both M; Ebert U; Gross G; Schoemaker H; Draguhn A; Wicke K; Nimmrich V
    Neuroscience; 2009 Sep; 162(4):1081-90. PubMed ID: 19477243
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Transgenic Alzheimer mice in a semi-naturalistic environment: more plaques, yet not compromised in daily life.
    Lewejohann L; Reefmann N; Widmann P; Ambrée O; Herring A; Keyvani K; Paulus W; Sachser N
    Behav Brain Res; 2009 Jul; 201(1):99-102. PubMed ID: 19428622
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The mitochondrial permeability transition pore: Is it formed by the ATP synthase, adenine nucleotide translocators or both?
    Baines CP; Gutiérrez-Aguilar M
    Biochim Biophys Acta Bioenerg; 2020 Oct; 1861(10):148249. PubMed ID: 32569662
    [No Abstract]   [Full Text] [Related]  

  • 35. Amyloid toxicity and platelet-activating factor signaling.
    Sirangelo I; Irace G; Balestrieri ML
    J Cell Physiol; 2013 Jun; 228(6):1143-8. PubMed ID: 23169529
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Neuronal death and neuroprotection: a review.
    Repici M; Mariani J; Borsello T
    Methods Mol Biol; 2007; 399():1-14. PubMed ID: 18309921
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Molecular and biological bases of post-traumatic amyloidosis and apoptosis (review of the literature in 2000-2003 years].
    Kasumova SIu
    Zh Vopr Neirokhir Im N N Burdenko; 2004; (1):45-8. PubMed ID: 15055014
    [No Abstract]   [Full Text] [Related]  

  • 38. Suppression of amyloidogenesis in a mouse model by corticosteroid intervention.
    Shtrasburg S; Lidar M; Pras M; Pariente C; Gal R; Livneh A
    Transl Res; 2007 Jul; 150(1):66-72. PubMed ID: 17585865
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Study into molecular targets of a neuroprotective compound dimebon using a transgenic mice line].
    Shelkovnikova TA; Ustiugov AA; Kokhan VS; Tarasova TV; Medvedeva VK; Khritankova IV; Bachurin SO; Ninkina NN
    Biomed Khim; 2014; 60(3):354-63. PubMed ID: 25019398
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Introduction to the iPS Cells for Ischemic Stroke, Traumatic Brain Injury, and Other Brain-Related Diseases Special Issue.
    Sharlow ER
    Assay Drug Dev Technol; 2020; 18(2):77. PubMed ID: 32069087
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.